December 20th 2023
There is no vaccine against the hepatitis C virus. A subscription-like payment model may help overcome some of the cost issues posed by direct-acting antivirals.
FDA Approves New Alzheimer's Drug, Leqembi. Can It Escape Aduhelm's Fate?
January 7th 2023Leqembi's starting price is almost half of what Aduhelm's was and the FDA-approved label narrows use to people with early disease. But Medicare coverage restrictions may still apply and there is concern about a side effect called ARIA (amyloid related imaging abnormalities).
Read More
Well-Administered Coumadin No Worse for Mental Function Than Pradaxa, Study Finds
December 14th 2022Pradaxa (dabigatran) and Coumadin (warfarin) came out even in this randomized study. The Brazilian researchers who conducted the study said one explanation for the result is that use of Coumadin was exceptionally well managed because the patients were enrolled a study.
Read More
Differences in Patient Characteristics, Treatment of EoE by Allergists and Gastroenterologists
December 12th 2022Most (91%) of the patients were seen by gastroenterologists. Those seen by allergists were more likely to have comorbid atopic conditions, such as asthma, allergic rhinitis and atopic dermatitis.
Read More
Long-term Use of Dupixent Effective for Patients With Asthma Regardless of CRSwNP Status
December 9th 2022Patients with severe asthma with or without coexisting chronic rhinosinusitis and nasal polyps (CRSwNP) experienced continued improvements in exacerbations and lung function in an extension study.
Read More
Variation by Age of EoE Symptoms May Contribute to Delayed Diagnosis for Some Patients
December 6th 2022Patients with eosinophilic esophagitis experience a range of symptoms that can vary by age, which may contribute to younger patients experiencing a delay in diagnosis, according to a poster presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting.
Read More
Real-World Study Shows Dupixent Improves AD Symptoms in Children Under 12 Years
October 5th 2022A real-world study of children with moderate-to-severe atopic dermatitis (AD) in China found Dupixent can reduce symptoms and improve pruritus. Traditional therapies had little effect, according to the researchers.
Read More
Diabetes Medications Find New Life as Weight-Loss Drugs
July 21st 2022Novo Nordisk’s Saxenda (liraglutide) and Wegovy (semaglutide) are leading the way for a new crop of drugs that reduce appetite. But their cost-effectiveness is in question, and many payers are saying no to coverage — for now.
Read More
Lower limb amputations are devastating for people living with diabetes, particularly for Black Americans facing poor access to comprehensive care. A coordinated, data-driven national prevention strategy is the only way to curb this growing epidemic for all at-risk populations.
Read More